v3.26.1
Composition of Certain Consolidated Financial Statement Line Items - Accrued expenses and other current liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Composition of Certain Consolidated Financial Statement Line Items    
Accrued compensation $ 8,013 $ 12,434
Accrued research and development expenses 17,348 12,404
Accrued clinical expenses 22,015 15,791
Accrued professional services 3,138 4,470
Accrued other liabilities 1,873 1,444
Total accrued expenses and other current liabilities $ 52,387 $ 46,543